Artelo Biosciences, Inc.
ARTL· Nasdaq
ARTLArtelo Biosciences, Inc.
Filed Jul 13, 2018 · 10-Q · 43 days after period end · 0001640334-18-001368
| Metric | Q3 2018 | Q3 2017 | Q3 2016 | Q3 2015 |
|---|---|---|---|---|
| Net Income | -$577.86K | -$96.63K | -$5.05K | -$2.50K |
| EPS Diluted | -$0.36 | -$0.01 | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Artelo Biosciences, Inc. · CIK 1621221 · Engraved from SEC EDGAR
ended May 31, 2018 · filed Jul 13, 2018 · 43 d after period end
